1988
DOI: 10.1055/s-0038-1647000
|View full text |Cite
|
Sign up to set email alerts
|

A Study of the Effect of Ethamsylate (Dicynene) on the Bleeding Time, von Willebrand Factor Level and Fibrinolysis in Patients with von Willebrand’s Disease

Abstract: SummaryNine patients with clinically moderate or severe Type I von Willebrand’s disease were treated for 2 weeks with ethamsylate (2 g/day in four equal doses) and with a matched placebo in a randomised double-blind trial. Template bleeding time, von Willebrand factor activity (ristocetin co-factor) and antigen, euglobulin lysis time and type I tissue plasminogen activator inhibitor were determined before and at the end of each treatment period. None of these parameters showed any significant change attributab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1992
1992
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…This study did not find a significant change in type I tissue plasminogen activator inhibitor, a marker of fibrinolysis in people with Von Willebrand disease following treatment with etamsylate (Hutton et al. 1988 ).…”
Section: Discussionmentioning
confidence: 77%
“…This study did not find a significant change in type I tissue plasminogen activator inhibitor, a marker of fibrinolysis in people with Von Willebrand disease following treatment with etamsylate (Hutton et al. 1988 ).…”
Section: Discussionmentioning
confidence: 77%